Medelis Full Service CRO – Two Combined Experiences. One Clear Vision.
Medelis and WCCT merged in 2016 to provide sponsors with access to an expanded depth and breadth of clinical research offerings. The Medelis brand is now responsible for our entire late-stage, global clinical development offering.
Agile and Collaborative CRO Services
Our CRO services can guide your journey through the clinic. Gain the comfort of a global, specialized team that uses an innovative, agile and collaborative approach to optimize all areas of your clinical development program.
Clinical Research Expertise
Our DNA as a specialty oncology CRO services provider with access to 400 sites and research networks in the U.S. and Europe extends our clinical research standards to key therapeutic areas: cardiovascular, dental, gastrointestinal, immunology and allergy, infectious disease and vaccines, oncology, ophthalmology, respiratory, and more.
Expertise in immunotherapy, targeted therapies and complex oncology studies from strategic development through clinical operations.
Immunology and Allergy
Leading the clinical development of new therapies and vaccines for the prevention and treatment of infectious and immune-mediated diseases.
Highly trained investigators, owned sites and access to over 50,000 patients for full-service research capabilities.